WEDNESDAY, Nov. 13, 2024 (HealthDay News) — The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disorder, helping them to avoid crises that require hospitalization, new research shows. Numerous studies had already hinted that semaglutide might act on appetite centers in the brain toContinue Reading

WEDNESDAY, Nov. 13, 2024 (HealthDay News) — People are at higher risk of schizophrenia if they indulge in psychedelic drugs, a new study warns. Patients who land in the ER following hallucinogen use have a 21-fold higher risk of developing schizophrenia compared to the general population, Canadian researchers report. EvenContinue Reading

TUESDAY, Nov. 5, 2024 (HealthDay News) — Banning menthol cigarettes could help convince smokers quit the habit, a new study finds. People who prefer menthol cigarettes would rather buy nicotine gum or other nicotine replacement therapies than switch to traditional tobacco cigarettes, researchers reported recently in the journal Drug andContinue Reading

FRIDAY, Oct. 24, 2024 (HealthDay News) — Certain gut microbes might be linked to a person’s risk of developing Parkinson’s disease, a new study suggests. People prescribed multiple courses of penicillin antibiotics have a modestly lower risk of developing Parkinson’s, researchers found. Those antibiotics might be affecting bacterial populations inContinue Reading

TUESDAY, Oct. 22, 2024 (HealthDay News) — At-home brain stimulation therapy can safely and effectively treat severe to moderate depression, a new clinical trial shows. Rates of treatment response and depression remission were three times higher in people receiving the noninvasive brain stimulation, researchers said. “The study results bring promiseContinue Reading